Thomas R Einarson
Biographic Data
| ID | 6418607 |
|---|---|
| NAME | Thomas R Einarson |
| GIVEN NAMES | Thomas R |
| FAMILY NAME | Einarson |
| SIGNATURE | EINARSON T R |
| AFFILIATIONS | University of Toronto |
| ORCID | 0000-0003-3865-2533 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult Neurology Unit over 36 months, which has evaluated the results of a CP service from a hospital and Public Health System (PHS) perspective. The interventions were classified into 14 categories and …
Out-of-pocket expenditures and coping strategies for people living with HIV
Our objective was to estimate the out-of-pocket expenditure related to medical and non-medical items on health care covered by individuals or household members, and to describe coping strategies they use to meet the financial burden. We undertook a cross-sectional survey with a convenience sample of 540 adults with HIV living in urban areas of Bogotá, Colombia. Univariate and bivariate analyses were done. We found that although 95% of the patient…
Cost-of-illness study of type 2 diabetes mellitus in Colombia
We estimated the annual cost of T2DM for Colombia from societal, Ministry of Health, and Colombian Health System perspectives. We also estimated annual direct cost per patient and the cost of treating diabetes and macrovascular complications. The economic burden is substantial and comparable to results for other countries. The model showed a logical disease progression
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia
Amitriptyline is cost-effective in comparison to fluoxetine and venlafaxine in Colombia. However, the cost of venlafaxine was estimated for the brand-name product, as generics were not currently available. These cost-effectiveness results can be substantially affected by the presence of generics or drug cost regulations
Prevalence of Depression During Pregnancy
No prominent works on this page.
Prevalence of Depression During Pregnancy
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia
Amitriptyline is cost-effective in comparison to fluoxetine and venlafaxine in Colombia. However, the cost of venlafaxine was estimated for the brand-name product, as generics were not currently available. These cost-effectiveness results can be substantially affected by the presence of generics or drug cost regulations
Cost-of-illness study of type 2 diabetes mellitus in Colombia
We estimated the annual cost of T2DM for Colombia from societal, Ministry of Health, and Colombian Health System perspectives. We also estimated annual direct cost per patient and the cost of treating diabetes and macrovascular complications. The economic burden is substantial and comparable to results for other countries. The model showed a logical disease progression
Out-of-pocket expenditures and coping strategies for people living with HIV
Our objective was to estimate the out-of-pocket expenditure related to medical and non-medical items on health care covered by individuals or household members, and to describe coping strategies they use to meet the financial burden. We undertook a cross-sectional survey with a convenience sample of 540 adults with HIV living in urban areas of Bogotá, Colombia. Univariate and bivariate analyses were done. We found that although 95% of the patient…
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult Neurology Unit over 36 months, which has evaluated the results of a CP service from a hospital and Public Health System (PHS) perspective. The interventions were classified into 14 categories and …
Medicine (4 works) · Nursing (3 works) · Public health (3 works) · Economic growth (2 works) · Economics (2 works) · Environmental health (2 works) · Family medicine (2 works) · Gerontology (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works)